Takai A, Hirai S, Watanabe I, Hiraiwa T, Abe N, Omori M, Muroda T, Nakajima S, Nakada Y, Tanada K, Senda N, Tanaka K, Makino H
Jpn J Antibiot. 1980 Oct;33(10):994-1018.
General pharmacological properties of cefoperazone (CPZ) were studied in various experimental animals. CPZ showed the following effects with intravenous injection to experimental animals. On the central nervous system, CPZ caused vomiting in dogs at 500 mg/kg, pyrexia and slow waves in electroencephalogram in rabbits at 1,000 mg/kg. On the motor and sensory nervous systems, CPZ enhanced slightly the twitch tension of musculus gastrocnemius induced by electrical stimulation in rats at 500 mg/kg. On the respiratory, cardiovascular and autonomic nervous systems, CPZ increased transiently the respiratory rate and potentiated the depressor response to Ach at 125 mg/kg, increased femoral blood flow, potentiated the pressor response to Adr in dogs and decreased the contraction of nictitating membrane induced by electrical stimulation in cats at 500 mg/kg, and then raised the systolic blood pressure in rabbits at 1,000 mg/kg. On the blood, CPZ decreased ChE activity in rabbit plasma at 250 mg/kg, prolonged bleeding time in mice at 500 mg/kg and prothrombin time in rabbits at 1,000 mg/kg. On the smooth muscle organs, CPZ enhanced slightly gastric motility in rabbits and ileal motility in guinea pigs at 62.5 and 125 mg/kg respectively, and promoted gastrointestinal propulsion of BaSO4 meal in mice at 1,000 mg/kg. On the urinary organ, CPZ increased urine volume and electrolytes excretion in dogs at 500 mg/kg. Subcutaneous injection of CPZ scarcely showed any significant effect in experimental animals under the dose of 2,000 mg/kg. In the in vitro experiments, CPZ enhanced slightly the motility of isolated rabbit gastrointestinal tract at 10(-3) g/ml. Assuming the single clinical dose of CPZ should be 10 approximately 40 mg/kg, it is concluded that the occurrence of pharmacological effects observed in experimental animals seems to be very rare clinically.
在各种实验动物中研究了头孢哌酮(CPZ)的一般药理学特性。对实验动物静脉注射CPZ后显示出以下效应。在中枢神经系统方面,CPZ在犬中剂量为500mg/kg时引起呕吐,在兔中剂量为1000mg/kg时引起发热和脑电图慢波。在运动和感觉神经系统方面,CPZ在大鼠中剂量为500mg/kg时轻微增强电刺激诱发的腓肠肌抽搐张力。在呼吸、心血管和自主神经系统方面,CPZ在剂量为125mg/kg时短暂增加呼吸频率并增强对乙酰胆碱的降压反应,增加股血流量,在犬中增强对肾上腺素的升压反应,在猫中剂量为500mg/kg时减少电刺激诱发的瞬膜收缩,然后在兔中剂量为1000mg/kg时升高收缩压。在血液方面,CPZ在兔血浆中剂量为250mg/kg时降低胆碱酯酶活性,在小鼠中剂量为500mg/kg时延长出血时间,在兔中剂量为1000mg/kg时延长凝血酶原时间。在平滑肌器官方面,CPZ在兔中剂量为62.5mg/kg、在豚鼠中剂量为125mg/kg时分别轻微增强胃动力和回肠动力,在小鼠中剂量为1000mg/kg时促进硫酸钡餐的胃肠推进。在泌尿器官方面,CPZ在犬中剂量为500mg/kg时增加尿量和电解质排泄。皮下注射CPZ在剂量达2000mg/kg时在实验动物中几乎未显示任何显著效应。在体外实验中,CPZ在浓度为10(-3)g/ml时轻微增强离体兔胃肠道的动力。假设CPZ的单次临床剂量应为约10至40mg/kg,得出结论:在实验动物中观察到的药理学效应在临床上似乎非常罕见。